Noticias de SRPT_US

Noticias del mercado

Últimas noticias sobre SRPT_US — 190 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: SRPT_US ✕ 190 resultados
27/03/2026 SRPT_US — Stock Titan
Vanguard realigns reporting; reports 0 shares of Sarepta (SRPT)
26/03/2026 SRPT_US — Yahoo Finance
Assessing Sarepta Therapeutics (SRPT) Valuation After Early siRNA Trial Results Spark Share Price Rebound
26/03/2026 SRPT_US — Yahoo Finance
SRPT Stock Surges on Promising Early Results From siRNA Programs
26/03/2026 SRPT_US — GuruFocus
Sarepta Therapeutics (SRPT) Retains 'Underperform' Rating by Nee
26/03/2026 SRPT_US — Steptoe
Federal Circuit Holds Gene Therapy Claims Patent Eligible in REGENXBIO v. Sarepta
26/03/2026 SRPT_US — Seeking Alpha
Sarepta Therapeutics - It's Too Early To Get Excited About siRNA Data (NASDAQ:SRPT)
26/03/2026 SRPT_US — Yahoo Finance
Sarepta Therapeutics (SRPT) Soars 35.0%: Is Further Upside Left in the Stock?
25/03/2026 SRPT_US — Benzinga
Why Is Sarepta Therapeutics Stock Exploding Today?
25/03/2026 SRPT_US — Yahoo Finance
Sarepta Therapeutics’ experimental siRNA therapies show promising early results
25/03/2026 SRPT_US — Business Wire
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
25/03/2026 SRPT_US — MEXC
Sarepta Therapeutics (SRPT) Stock Climbs Following Positive siRNA Muscular Dystrophy Trial Results
25/03/2026 SRPT_US — BioSpace
Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
25/03/2026 SRPT_US — Proactive financial news
Sarepta Therapeutics’ experimental siRNA therapies show promising early results
25/03/2026 SRPT_US — Yahoo Finance
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
25/03/2026 SRPT_US — Seeking Alpha
Sarepta posts data for muscular dystrophy drugs (SRPT:NASDAQ)
25/03/2026 SRPT_US — 24/7 Wall St.
Sarepta Therapeutics Zooms 20% Higher on Promising Clinical Data: Is SRPT Ready for a Bigger Breakout?
25/03/2026 SRPT_US — Seeking Alpha
Sarepta Therapeutics, Inc. (SRPT) Discusses Preliminary Phase I/II Data for SRP-1001 in FSHD1 and SRP-1003 in DM1 - Slideshow (NASDAQ:SRPT) 2026-03-25
25/03/2026 SRPT_US — Yahoo Finance
Sarepta (SRPT) Skyrockets 35% on Morgan Stanley PT Hike, Stellar Trial Results
25/03/2026 SRPT_US — Sarepta Therapeutics
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
25/03/2026 SRPT_US — Yahoo Finance
Sarepta Therapeutics’ experimental siRNA therapies show promising early results

Página 9 de 10

keyboard_arrow_up